rss | search | contact | donate

• HOME
• ABOUT US
  • Board
  • Contact Us
  • Institut Pasteur
  • U.S. Scientific Relations
    • National Academy of Sciences
    • American Academy of Microbiology
    • Dept of Health and Human Services
  • Historic Relations
• GIVING
  • Ways of Giving
  • Major Giving
  • Donate Online
  • Bequests
  • Annual Gala
• PROGRAMS
  • Program Deadlines
  • Postdoctoral Fellowships
    • Past Fellows
  • Undergraduate Internships
    • Past Interns
  • Visiting Scholars
    • Past Scholars
• NEWS & PUBLICATIONS
  • Subscribe
  • Read Current Issue
  • Pasteur Perspectives Archives
  • Recent Press Releases
  • Pasteur Nobel Prize Winners
  • Other Publications
• EVENTS
  • Annual Award Gala
  • Past Honorees
  • Past Gala Photos
• PASTEUR REMEMBRANCES
  • Pasteur Institutes USA
  • Pasteur Memorials USA
• CONTACT US

Board & Staff

Contact Us

Institut Pasteur

U.S. Scientific Relations

Historic Relations

Biography: Francois Maisonrouge

Francois Maisonrouge is a Senior Managing Director in Evercore Partners’ advisory business.

At Evercore, Mr. Maisonrouge was involved in advising Sanofi on its acquisition of Genzyme and of Merck’s 50% stake in Merial, Terumo on its acquisition of CaridianBCT, Wyeth on its combination with Pfizer, Movetis on its sale to Shire, and TPG on its acquisition of IMS Health.

Prior to joining Evercore, Mr. Maisonrouge was a Managing Director and Chairman of Life Sciences at Credit Suisse where he worked extensively in the fields of pharmaceuticals, specialty pharmaceuticals, biotechnology and medical technology.

Mr. Maisonrouge has an M.S. in Engineering from Ecole Centrale de Lyon and an M.B.A. from Harvard Business School. He is a member of the Board of Advisors of the Harvard Business School Health Care Initiative, and the Chairman of the American Advisory Board of the Pasteur Foundation.

Return to Board & Staff List »

Home | About Us | Giving | Programs | News & Publications | Events | Remembrances | Contact Us | Sitemap | Donate